ARDELYX, INC. Total Liabilities
ARDELYX, INC. (ARDX) had Total Liabilities of $426.88 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2026-08-06
- 2026-06-30: Liabilities $426.88M.
- 2026-03-31: Liabilities $355.88M.
- 2025-12-31: Liabilities $334.65M.
- 2025-09-30: Liabilities $331.89M.
| Period end | Liabilities |
|---|---|
| 2026-06-30 | $426.88M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $355.88M 10-Q · filed 2026-04-30 |
| 2025-12-31 | $334.65M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $331.89M 10-Q · filed 2025-10-30 |
| 2025-06-30 | $327.24M 10-Q · filed 2025-08-04 |
| 2025-03-31 | $264.52M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $262.46M 10-K · filed 2026-02-19 |
| 2024-09-30 | $209.57M 10-Q · filed 2024-10-31 |
| 2024-06-30 | $196.50M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $191.49M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $130.76M 10-K · filed 2025-02-20 |
| 2023-09-30 | $98.22M 10-Q · filed 2023-10-31 |
| 2023-06-30 | $88.04M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $91.60M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $91.74M 10-K · filed 2024-02-22 |
| 2022-09-30 | $77.81M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $78.57M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $65.22M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $67.30M 10-K · filed 2023-03-02 |
| 2021-09-30 | $89.42M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $87.41M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $79.48M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $75.45M 10-K · filed 2022-02-28 |
| 2020-09-30 | $67.22M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $70.99M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $67.56M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $73.13M 10-K · filed 2021-03-08 |
| 2019-09-30 | $70.25M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $69.36M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $74.29M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $67.52M 10-K · filed 2020-03-06 |
| 2018-09-30 | $65.22M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $65.12M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $13.86M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $18.59M 10-K · filed 2019-03-06 |
| 2017-09-30 | $16.47M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $19.14M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $20.08M 10-Q · filed 2017-05-05 |
| 2016-12-31 | $19.98M 10-K · filed 2018-03-14 |
| 2016-09-30 | $18.42M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $14.77M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $12.75M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $8.04M 10-K · filed 2017-02-17 |
| 2015-09-30 | $12.94M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $5.93M 10-Q · filed 2015-08-12 |
| 2015-03-31 | $47.40M 10-Q · filed 2015-05-12 |
| 2014-12-31 | $52.73M 10-K · filed 2016-03-04 |
| 2014-09-30 | $54.43M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $60.61M 10-Q · filed 2014-08-08 |
| 2013-12-31 | $50.23M 10-K · filed 2015-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |